• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • MANUFACTURERS
  • HEADHUNTERS
  • COMPANIES

SPINEMarketGroup

Spine Industry News

  • HOME
  • 2026
  • 2025
  • 2024
  • BROCHURES
  • ARTICLES
  • PRODUCT LIBRARY

MiRus Receives New Technology Add-on Payment (NTAP) for EUROPA™ Posterior Cervical Fusion System

August 2, 2025 By SPINEMarketGroup

ATLANTA, Aug. 1, 2025 /PRNewswire/ — MiRus has received New Technology Add-on Payment (NTAP) from the Centers for Medicare and Medicaid Services (CMS) for the EUROPA® Posterior Cervical System, based on it’s proprietary rhenium alloys, for treatment of the cervical and upper thoracic spine. 

The EUROPA® PCF system is built around a 2.9 mm MoRe rod which is much smaller than current commercial systems. The lower diameter rod allows low-profile pedicle screw tulips leading to less invasive surgery and less hardware prominence in smaller patients. Although lower diameter, MoRe rods provide a superior level of rigidity, strength, and fatigue resistance which reduces the risk of spine rod fractures compared to current systems. The EUROPA® PCF System was awarded Breakthrough Device Designation by the FDA.

“I have used the 4.5mm MoRe rod TL system for complex cases and have had good results,” stated Han Jo Kim MD, Professor of Orthopedic Surgery at the Hospital for Special Surgery, New York “There is tremendous potential in what this proprietary alloy (MoRe) can accomplish in spine surgery, offering implants that are lower profile, more durable and stronger.”

“We are pleased that CMS has recognized the EUROPA® PCF System as the superior option for treating the cervical and upper thoracic spine, enabling hospitals to receive reimbursement through the NTAP program and ensuring Medicare patients have access to this breakthrough technology,” commented Mahesh Krishnan, Chief Commercial Officer.

“Currently the rates of spine implant failures and revision surgeries for patients remain unacceptably high,” commented Jordan Bauman, VP of Regulatory and Quality. “with EUROPA® PCF, spine surgeons will be able to provide durable and less invasive surgery for their cervicothoracic patients. This is another step forward in our mission to provide less invasive and more durable devices across a broad spectrum of disease states.”

About MiRus, LLC.
MiRus is a life sciences company headquartered in Atlanta, Georgia that has developed and is commercializing proprietary novel biomaterials and implants that are transforming medicine by making surgeries less invasive and implants safer and more durable. www.mirusmed.com. 

Statements made in this press release that look forward in time or that express beliefs, expectations or hopes regarding future occurrences or anticipated outcomes are forward-looking statements. A number of risks and uncertainties such as risks associated with product development and commercialization efforts, expected timing or results of any clinical trials, ultimate clinical outcome and perceived or actual advantages of the Company’s products, market and physician acceptance of the products, intellectual property protection, and competitive offerings could cause actual events to adversely differ from the expectations indicated in these forward looking statements. The EUROPA® Posterior Cervical System is not FDA approved.

* MiRus® , EUROPA®, MoRe® are all trademarks of MiRus, LLC.

Contact:
Pam Cowart
VP of Clinical Affairs
pcowart@mirusmed.com
770-861-4804

SOURCE MiRus

Related Posts:

  • EUROPA® PCF system
  • MiRus Receives Breakthrough Device Designation for…
  • MiRus Announces First Cases with EUROPA® Posterior…

Filed Under: NEWS Tagged With: 2025

Primary Sidebar

PLATINUM SPONSORS

EXALTA 2LOGO-min
GLOBAL biomedica
NORMED newLOGO-min
GENESYS SPINE
SPINEGUARD2025
Dymicron 2
GSMEDICAL2025
spinewaygroup
RUTHLESS SPINE
RUDISHAUER
NGMEDICAL
LfC
ispine
CENTINEL SPINE
TSUNAMI MEDICAL
syntropiq logo
A-SPINE
L&Kmodelo log

POPULAR POST LAST 90 DAYS

  • Globus Medical and Synaptive: Why the Rumors Deserve…
  • What Globus Medical Really Bought With Higgs Boson Health
  • BROCHURES
  • Globus Medical Announces Acquisition of Higgs Boson…
  • Neck and Neck: Is Globus Finally About to Overtake…
  • Who Runs DePuy Synthes? The CEO Fight That Killed…
  • Globus Medical to Showcase SCRIPT™ Patient-Specific…
  • J&J’s $21B DePuy Synthes Bet Could End in…
  • Federal Circuit Backs Globus Medical in Spinal…
  • Centinel Spine Files for NYSE IPO After 42% Jump in…
  • COMPANIES
  • DePuy Synthes for Sale: Who Could Actually Buy the…
  • Do Spine Companies Really Need So Many Implants?…
  • Record Earnings, Discount Valuation: What Globus…
  • New CFO, New AI Chief and a Patent Fight: What Is…
  • Globus Medical Reports Third Quarter 2026 Results…
  • CD HORIZON® SOLERA™ System
  • (UPDATED 2026) More Than 100 Options, No Single…
  • 3D-Printed Cages Are Everywhere. Has the Technology…
  • Top Expandable Cages of 2025: Which Lumbar Implants…
  • (UPDATED 2025): 6 Artificial Cervical Discs You’ll…
  • Globus Medical Acquires Synaptive Medical,…
  • Forty Cervical Discs, One 3% Market: The Fight to…
  • SYMPHONY Occipito-Cervico-Thoracic (OCT) System
  • What Is a Spine Hub, and Why Did Avesi Invest in New…
  • Whatever Happened to the Translational Cervical…
  • Posterior Cervical: The Segment Everyone Serves and…
  • Thinking About a Spine Robot? Your 2026 Guide to the…
  • Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System
  • Is DePuy Back in the Spine Fight? Why DePuy Really…
  • LAST 5 VIDEOS PUBLISHED

    1. GS Medical: QUASAR™ Stand-Alone ACIF
    2. SI-BONE: iFuse Granite Onyx™
    3. NovaSpine: DIVA Cervical
    4. Xenix Medical: Riva Modular Fixation System
    5. Spinal Elements: Overwatch® PCF

    Footer

    Contact us:

    spinemarketgroup@gmail.com info@thespinemarketgroup.com

    • LinkedIn
    • Twitter
    • YouTube

    PRIVACY POLICY

    • Legal
    • PRODUCT LIBRARY

    Copyright © 2026 · SPINEMarketGroup